🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
NCT05235516Locally Advanced Cervical Carcinoma
DrugsCadonilimab·Cisplatin
Akeso
Phase 3
636
Beijing, Guiyang, Wuhan, Changsha, Shanghai, Chengdu, Hangzhou
2022-06-21
Active, closed
Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer
NCT05444491Colorectal Cancer
Singlera Genomics Inc.
Observational
800
Beijing, Chengdu, Guangzhou, Haerbin, Shanghai, Shenzhen, Taiyuan
2022-06-20
Active, closed
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
NCT05283720Non-Hodgkin Lymphoma
DrugsDoxorubicin Hydrochloride·Golcadomide·Epcoritamab·Ibrutinib
Genmab
Phase 2
264
Beijing, Shanghai
2022-06-14
Recruiting
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
NCT05316493Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity
DrugMegestrol Acetate
Xiaojun Chen
Phase 2/3
172
Shanghai
2022-06-13
Active, closed
Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung Cancer
NCT05407155Non-small Cell Lung Cancer Metastatic
Fudan University
Not applicable
56
Shanghai
2022-06-09
Active, closed
Effect of FMD on Colorectal Cancer Patients
NCT05384444Fasting Mimicking Diet, Colorectal Cancer
Fudan University
Not applicable
602
Shanghai
2022-06-08
Recruiting
Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)
NCT05382728NSCLC, EGFR Activating Mutation
TYK Medicines, Inc
Phase 3
680
Changsha, Shanghai
2022-06-08
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
NCT05382559Solid Tumor
DrugsNanoparticle Albumin-Bound Paclitaxel·Setidegrasib·Liposomal Irinotecan·Fluorouracil
Astellas Pharma Inc
Phase 1
681
Beijing, Xuhui District, Shanghai
2022-06-08
Recruiting
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
NCT05365581Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma
DrugsASP2138·Ramucirumab·Fluorouracil·Leucovorin
Astellas Pharma Global Development, Inc.
Phase 1
398
Guangzhou, Zhengzhou, Wuhan, Shanghai, Hangzhou
2022-06-07
By invitation
Preservation of Venous Valvular Function After PMT for Acute DVT
NCT05588284Acute Deep Venous Thrombosis of Femoral Vein (Disorder)
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
100
Chuzhou, Shanghai, Taizhou
2022-06-06
Active, closed
Impact of Partial Capsule Decortication on Device-related Infection in Patients Receiving Cardiac Implantable Electronic Device Replacement
NCT05390216Pacemaker Complication, Infections
Shanghai Zhongshan Hospital
Not applicable
1,016
Shanghai
2022-06-05
Active, closed
AMP SCZ® Observational Study: PREDICT-DPACC
NCT05905003Clinical High Risk, Psychosis, Remission, Conversion
Brigham and Women's Hospital
Observational
2,617
Shanghai
2022-06-02
Recruiting
Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment
NCT05326399Liver Transplantation, Renal Insufficiency, Chronic
RenJi Hospital
Observational
369
Shanghai
2022-06-01
Not yet open
Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes
NCT05294653Atherosclerotic Cardiovascular Disease, Childhood Diabetes Mellitus, Juvenile Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
300
Shanghai
2022-06-01
Active, closed
A Multi-center Retrospective Study of INO Treating B-ALL
NCT07238907Acute Lymphoblastic Leukaemia, Acute Lymphoblastic Leukaemias (ALL), Inotuzumab Ozogamicin, Venetoclax
DrugInotuzumab ozogamicin
Ruijin Hospital
Observational
102
Shanghai
2022-06-01
By invitation
Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study
NCT07346534Low Rectal Cancer, Rectal Neoplasms, Colorectal Cancer
Shanghai 10th People's Hospital
Not applicable
300
Shanghai
2022-06-01
Recruiting
Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies
NCT05436561Disease-free Survival
Shanghai Jiao Tong University School of Medicine
Phase 2
61
Shanghai
2022-06-01
Recruiting
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)
NCT05081401Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, Pre-XDR-TB
Huashan Hospital
Phase 3
1,050
Guiyang, Kaili, Liupanshui, Zunyi, Shanghai
2022-05-23
Recruiting
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
NCT05430373Solid Tumors, Adult
DrugGT101
Grit Biotechnology
Phase 1
31
Beijing, Chongqing, Shanghai, Chengdu, Tianjin
2022-05-23
Active, closed
Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
NCT05293964Breast Cancer
DrugsSIM0270·Everolimus·Palbociclib
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
214
Shanghai
2022-05-18
Recruiting
Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma
NCT05348213Diffuse Large B Cell Lymphoma
DrugsR-Ice·Tofacitinib·Decitabine·Zanubrutinib
Ruijin Hospital
Phase 2
76
Shanghai
2022-05-16
Active, closed
A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
NCT06209281Myopia
DrugAtropine sulfate eye
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Phase 3
526
Shanghai
2022-05-13
Recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
NCT05307705Breast Cancer
DrugsAnastrozole, Exemestane·Imlunestrant·Abemaciclib·Letrozole
Eli Lilly and Company
Phase 1
260
Beijing, Nanchang, Shanghai
2022-05-11
Recruiting
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
NCT05090891Fibrodysplasia Ossificans Progressiva (FOP)
DrugINCB000928
Incyte Corporation
Phase 2
98
Beijing, Shanghai
2022-05-05
Recruiting
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
NCT05179876Hypertension, Pulmonary
DrugsSelexipag·Macitentan
Actelion
Phase 3
280
Beijing, Changsha, Nanjing, Qingdao, Shanghai, Xi'an
2022-05-04
Active, closed
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease
NCT05280548Fabry Disease
DrugsMigalastat·Venglustat
Sanofi
Phase 3
104
Beijing, Chengdu, Guangzhou, Shanghai
2022-05-03
Recruiting
Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population
NCT05311137Atrial Fibrillation
Shanghai 10th People's Hospital
Observational
5,000
Shanghai
2022-05-01
Not yet open
Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms
NCT05316480Pancreatic Neuroendocrine Neoplasm
DrugNimotuzumab
Fudan University
Phase 2
42
Shanghai
2022-05-01
Recruiting
A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children
NCT04955210Critical Illness, Severe Sepsis
Children's Hospital of Fudan University
Observational
5,000
Shanghai
2022-04-30
Recruiting
A Study of CM350 in Patients With Advanced Solid Tumors
NCT05263960Advanced Solid Tumor
Keymed Biosciences Co.Ltd
Phase 1/2
248
Chengdu, Shanghai
2022-04-21
By invitation
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
NCT05303532Cancer
DrugDurvalumab
AstraZeneca
Phase 3
214
Beijing, Changsha, Hangzhou, Nanjing, Shanghai, Shenyang, Wenzhou, Xi'an
2022-04-19
Active, closed
Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3
NCT05222906Gaucher's Disease Type III
DrugsImiglucerase·Venglustat
Sanofi
Phase 3
43
Taipei, Beijing, Guangzhou, Shanghai
2022-04-18
Active, closed
A Study of ILB2109 in Patients With Advanced Solid Malignancies
NCT05278546Advanced Solid Tumor
Innolake Biopharm
Phase 1
48
Jinan, Shanghai
2022-04-11
Recruiting
Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
NCT06553911Respiratory Infectious Diseases, Artificial Intelligence, Medical Imaging
Huashan Hospital
Not applicable
2,000
Shanghai
2022-04-01
Active, closed
Olorofim Aspergillus Infection Study
NCT05101187Invasive Aspergillosis
F2G Biotech GmbH
Phase 3
225
Bengbu, Wuhan, Nanchang, Jinan, Shanghai, Xiaobailou, Wenzhou, Beijing
2022-03-31
Recruiting
A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
NCT05387304COVID-19
Ruijin Hospital
Observational
250,000
Shanghai
2022-03-29
Active, closed
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
NCT05277051Neoplasms
DrugsGSK5764227·Remzistotug·Nelistotug·Belrestotug
GlaxoSmithKline
Phase 1
152
Chengdu, Jinan, Shanghai, Wuhan
2022-03-22
Recruiting
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
NCT05387369COVID-19
DrugPaxlovid
Huashan Hospital
Observational
2,000
Shanghai
2022-03-21
Active, closed
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
NCT05009069Rectal Neoplasms, Rectal Cancer
DrugsTiragolumab·Fluorouracil·Atezolizumab·Capecitabine
Hoffmann-La Roche
Phase 2
58
Beijing, Guangzhou, Hangzhou, Shanghai, Shenyang
2022-03-18
Recruiting
Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
NCT05277688Cervical Cancer
Ruijin Hospital
Phase 3
340
Shanghai
2022-03-15
Active, closed
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
NCT05262400Breast Cancer, Solid Tumors
DrugsPF-07104091·PF-07220060
Pfizer
Phase 1/2
235
Changchun, Shanghai, Chengdu, Tianjin, Hangzhou
2022-03-14
Active, closed
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease
NCT05206773Fabry Disease
DrugVenglustat
Sanofi
Phase 3
122
Beijing, Shanghai, Taiyuan, Zhengzhou
2022-03-11
Recruiting
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
NCT05247268Endometrial Neoplasm Malignant Stage I
Fudan University
Phase 2
104
Shanghai
2022-03-11
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
NCT05201781Multiple Myeloma
DrugCilta-cel
Janssen Research & Development, LLC
Phase 4
295
Beijing, Chengdu, Fuzhou, Guangzhou, Hangzhou, Nanjing, Shanghai, Xi'an
2022-03-09
Recruiting
Prizvalve® Transcatheter Atrioventricular Valve Replacement Study
NCT05275088Atrioventricular Annular Calcification, Failed Prosthetic Atrioventricular Valve/ Annulus Repair
Shanghai NewMed Medical Co., Ltd.
Not applicable
15
Shanghai
2022-03-09
Active, closed
Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
NCT05280470Extensive-stage Small-cell Lung Cancer
DrugIfinatamab Deruxtecan
Daiichi Sankyo
Phase 2
187
Changchun, Changsha, Chengdu, Guangdong, Hangzhou, Linyi, Shanghai, Wuhan
2022-03-09
Recruiting
A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
NCT05205850Advanced Solid Tumor
DrugRC118
RemeGen Co., Ltd.
Phase 1/2
135
Shanghai, Hangzhou
2022-03-03
Recruiting
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
NCT04973306Esophageal Squamous Cell Carcinoma Stage II, Esophageal Squamous Cell Carcinoma Stage III
Shanghai Zhongshan Hospital
Phase 2/3
176
Shanghai
2022-03-02
Recruiting
Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study
NCT05347524Cancer
Shanghai Zhongshan Hospital
Observational
384
Shanghai
2022-03-01
Recruiting
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
NCT05597410Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment
Ruijin Hospital
Observational
3,418
Shanghai
2022-03-01
Recruiting
THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein
NCT05194423Tricuspid Valve Regurgitation
Changhai Hospital
Not applicable
150
Beijing, Guangzhou, Wuhan, Xi'an, Shanghai, Chengdu, Hangzhou
2022-03-01
Active, closed
A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
NCT05250973Amyloidosis
DrugsBortezomib·Daratumumab·Dexamethasone·Cyclophosphamide
Janssen Research & Development, LLC
Phase 2
151
Beijing, Chengdu, Hangzhou, Shanghai
2022-03-01
Recruiting
R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse
NCT05257018Diffuse Large B-cell Lymphoma
Fudan University
Phase 2
83
Shanghai, Ürümqi
2022-02-26
Active, closed
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
NCT05230537Age-Related Macular Degeneration
DrugIptacopan
Novartis Pharmaceuticals
Phase 2
170
Harbin, Tianjin, Shanghai
2022-02-17
Recruiting
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
NCT05263206Pruritus
DrugsFexofenadine·Dupilumab
Sanofi
Phase 3
284
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Shanghai, Suzhou, Wuhan
2022-02-15
Recruiting
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NCT05236686Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group
Not applicable
94
Shanghai
2022-02-15
Active, closed
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
NCT04417166Lymphoma, Extranodal NK-T-Cell
DrugPembrolizumab
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
30
Guangzhou, Shanghai
2022-02-11
Recruiting
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
NCT04779320Crohn's Disease (CD)
DrugVedolizumab
Takeda
Phase 3
120
Beijing, Zhengzhou, Shanghai, Hangzhou
2022-02-10
Active, closed
To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM
NCT05302648Multiple Myeloma
Hrain Biotechnology Co., Ltd.
Phase EARLY_PHASE1
18
Shanghai
2022-02-09
Recruiting
SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)
NCT04527419Carcinoma, Non-Small-Cell Lung
Fudan University
Not applicable
545
Shanghai
2022-02-09
Active, closed
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy
NCT05104775Hematologic Malignancies
DrugGNC-035
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
33
Guangzhou, Guiyang, Shijiazhuang, Wuhan, Shenyang, Shanghai, Yibin
2022-02-09
Recruiting
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
NCT03786003Carcinoma, Non-Small-Cell Lung
Fudan University
Not applicable
1,086
Shanghai
2022-02-09
Active, closed
A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
NCT05094336Advanced MTAP-null Solid Tumors
DrugsAnvumetostat·Docetaxel
Amgen
Phase 1/2
329
Chongqing, Fuzhou, Shanghai
2022-02-01
Recruiting
Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
NCT05595408Muscle Invasive Upper Tract Urothelial Carcinoma
RenJi Hospital
Observational
84
Shanghai
2022-02-01
Active, closed
Effectiveness of Treatments for Cirrhosis With Varicose Veins
NCT06961474Esophageal Varices Bleeding, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,900
Shanghai
2022-02-01
Recruiting
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
NCT05503667Lung Adenocarcinoma Stage III, Lung Adenocarcinoma Stage IV, EGFR Gene Mutation
DrugsFurmonertinib·Bevacizumab
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
96
Shanghai
2022-02-01
Recruiting
Correlation Between Intestinal Microecology Imbalance and Stroke in Young Adults
NCT05113043Ischemic Stroke, Hemorrhagic Stroke
Shanghai 6th People's Hospital
Observational
60
Shanghai
2022-02-01
Recruiting
Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN
NCT05260671Head and Neck Neoplasms, Recurrent Disease, Metastatic Cancer
DrugsPenpulimab·Cetuximab
Eye & ENT Hospital of Fudan University
Phase 2
48
Changchun, Shanghai
2022-01-25
Active, closed
China S3 PMS: SAPIEN 3 China Post Market Registry Study
NCT05168826Aortic Stenosis, Severe
Edwards Lifesciences
Observational
250
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Changsha, Shanghai, Xi’an
2022-01-24
Recruiting
To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors
NCT05260385Digestive System Tumors
DrugKC1036
Beijing Konruns Pharmaceutical Co., Ltd.
Phase 1/2
133
Beijing, Bengbu, Chongqing, Fujian, Henan, Hubei, Shandong, Shanghai
2022-01-24
Recruiting
PROfiling Based Endometrial Cancer Adjuvant Therapy
NCT05179447Endometrial Cancer Stage I, Endometrial Cancer Stage II
Women's Hospital School Of Medicine Zhejiang University
Not applicable
590
Wuhan, Jinan, Hangzhou, Beijing, Changsha, Guangzhou, Ningbo, Shanghai
2022-01-24
Recruiting
A Study of HS-20089 in Patients With Advanced Solid Tumors
NCT05263479Advanced Solid Tumor
DrugHS-20089
Shanghai Hansoh Biomedical Co., Ltd
Phase 1
177
Shanghai
2022-01-05
Active, closed
Effect of ALND With Vein Branches Reservation on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer
NCT05120180Breast Cancer Lymphedema
Xiangyun Zong
Not applicable
258
Shanghai, Hangzhou
2022-01-03
Recruiting
Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy
NCT05772208Nasopharyngeal Carcinoma
DrugsNimotuzumab·Camrelizumab
Fudan University
Phase 3
459
Shanghai
2022-01-01
Not yet open
Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
NCT05133050Alport Syndrome
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
510
Shanghai
2022-01-01
Not yet open
Prospective Acute Myocardial Infarction Data Bank
NCT05121818Acute Myocardial Infarction
Shanghai Zhongshan Hospital
Observational
3,000
Shanghai
2022-01-01
By invitation
Effect of Hysteroscopic Metroplasty on Reproductive Outcome in Patients with RIF
NCT06847386Recurrent Implantation Failure, T-Shaped Uterus
Shanghai First Maternity and Infant Hospital
Not applicable
200
Shanghai
2022-01-01
Recruiting
Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
NCT06391190Locally Advanced Cervical Carcinoma, Concurrent Chemoradiotherapy, Immunotherapy
RenJi Hospital
Phase 1/2
20
Shanghai
2022-01-01
Recruiting
Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02)
NCT07141251Thoracoabdominal Aortic Aneurysm, Endovascular Repair, Complex Aortic Aneurysms
Peking Union Medical College Hospital
Phase 1
60
Beijing, Chongqing, Guangzhou, Haikou, Zhengzhou, Jining, Shanghai
2022-01-01
Recruiting
China Lung Cancer Screening (CLUS) Study Version 3.0
NCT05494021Lung Cancer
Shanghai Chest Hospital
Not applicable
100,000
Shanghai
2022-01-01
Recruiting
Oriental Research AlliaNce of Acute Ischemic Stroke Given Endovascular Treatment
NCT05024292Ischemic Stroke
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
160
Zhangzhou, Shanghai
2022-01-01
Recruiting
Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy
NCT05674305Nasopharyngeal Carcinoma
DrugCisplatin
Fudan University
Phase 3
366
Shanghai
2022-01-01
Active, closed
Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC
NCT06569420Non-Small Cell Lung Cancer, ALK-positive, SAF-189s
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 3
275
Shanghai
2021-12-31
Active, closed
Crizotinib Continuation Clinical Study
NCT05160922NSCLC, ALCL, IMT
Pfizer
Phase 4
27
Beijing, Fuzhou, Guangzhou, Changchun, Wuhou District, Hangzhou, Shanghai
2021-12-27
Recruiting
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
NCT04925479Myeloid Leukemia, Philadelphia Positive
Novartis Pharmaceuticals
Phase 1/2
34
Hangzhou, Beijing, Shanghai, Tianjin
2021-12-27
Active, closed
A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC
NCT05054439Head and Neck Squamous Cell Carcinoma
DrugsSI-B001·Docetaxel·Paclitaxel
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
45
Guilin, Guiyang, Wuhan, Changsha, Shanghai, Chengdu, Hangzhou
2021-12-22
Active, closed
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
NCT04919226Neuroendocrine Tumors
DrugsEverolimus·Fluorouracil·Oxaliplatin
ITM Solucin GmbH
Phase 3
259
Shanghai, Wuxi
2021-12-21
Recruiting
Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
NCT04921527Ovarian Cancer, Relapsed or Refractory, Chiauranib, Paclitaxel
DrugsChiauranib·Paclitaxel
Chipscreen Biosciences, Ltd.
Phase 3
454
Shanghai
2021-12-20
Recruiting
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
NCT05067283Advanced Solid Tumors
DrugsCalderasib·Leucovorin·Cetuximab·Ivonescimab
Merck Sharp & Dohme LLC
Phase 1
830
Beijing, Fuzhou, Guangzhou, Wuhan, Changchun, Shanghai, Hangzhou
2021-12-17
Active, closed
Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer
NCT04685070Non-small Cell Lung Cancer Stage III
DrugAlmonertinib
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
56
Shanghai
2021-12-14
Active, closed
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)
NCT05156281Relapsing Multiple Sclerosis
DrugsTeriflunomide·Remibrutinib
Novartis Pharmaceuticals
Phase 3
1,007
Wuhan, Nanjing, Yinchuan, Taiyuan, Hangzhou, Wenzhou, Beijing, Shanghai
2021-12-13
Recruiting
Corheart 6: Long-term Cohort Study
NCT07094919Heart Failure
China National Center for Cardiovascular Diseases
Not applicable
160
Shenzhen, Zhengzhou, Wuhan, Nanjing, Beijing, Shanghai
2021-12-12
By invitation
TRIM25 in Septic Patients
NCT07320638Sepsis
Ruijin Hospital
Observational
65
Shanghai
2021-12-10
Active, closed
A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)
NCT05245968Gastrointestinal Stromal Tumors
Taiho Pharmaceutical Co., Ltd.
Phase 1
78
Beijing, Shanghai
2021-12-01
Recruiting
Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia
NCT05159349Schizophrenia
Shanghai Mental Health Center
Observational
1,200
Shanghai
2021-12-01
By invitation
Observation on Obesity Undergoing XOWI
NCT05122936Obesity, Traditional Chinese Medicine
Feng Tao
Observational
500
Shanghai
2021-11-30
Active, closed
PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.
NCT04963179Asherman Syndrome, Intrauterine Adhesion
Womed
Not applicable
160
Guangzhou, Hangzhou, Shanghai
2021-11-29
Recruiting
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor
NCT05194982Locally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
570
Chongqing, Guangzhou, Wuhan, Changsha, Shanghai, Taiyuan
2021-11-29
Recruiting
Ruijin Neurobank of Alzheimer's Disease and Dementia
NCT05623124Dementia
Ruijin Hospital
Observational
400
Shanghai
2021-11-22
Recruiting
A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
NCT05142475Breast Cancer, Treatment Side Effects, Advanced Breast Cancer, Effects of Immunotherapy
DrugTumor Infiltrating Lymphocytes
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1
50
Shanghai
2021-11-19
Rows per page Showing 3301–3400 of 3827
Previous 32 33 34 35 36 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=34

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.